772 related articles for article (PubMed ID: 33920096)
21. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
Wu CL; Tarng DC
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
[TBL] [Abstract][Full Text] [Related]
22. Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.
Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Nutrients; 2017 May; 9(5):. PubMed ID: 28498348
[TBL] [Abstract][Full Text] [Related]
23. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
24. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
25. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate.
Opdebeeck B; D'Haese PC; Verhulst A
Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31963891
[TBL] [Abstract][Full Text] [Related]
26. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
[TBL] [Abstract][Full Text] [Related]
27. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
28.
Hao QY; Yan J; Wei JT; Zeng YH; Feng LY; Que DD; Li SC; Guo JB; Fan Y; Ding YF; Zhang XL; Yang PZ; Gao JW; Li ZH
Gut Microbes; 2024; 16(1):2351532. PubMed ID: 38727248
[TBL] [Abstract][Full Text] [Related]
29. Vascular calcification and renal bone disorders.
Lu KC; Wu CC; Yen JF; Liu WC
ScientificWorldJournal; 2014; 2014():637065. PubMed ID: 25136676
[TBL] [Abstract][Full Text] [Related]
30. Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress.
Margiotta E; Caldiroli L; Callegari ML; Miragoli F; Zanoni F; Armelloni S; Rizzo V; Messa P; Vettoretti S
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357944
[TBL] [Abstract][Full Text] [Related]
31. Role of gut microbiota-derived metabolites on vascular calcification in CKD.
Yin L; Li X; Ghosh S; Xie C; Chen J; Huang H
J Cell Mol Med; 2021 Feb; 25(3):1332-1341. PubMed ID: 33369187
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease and the gut microbiome.
Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
[TBL] [Abstract][Full Text] [Related]
33. Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.
Laville SM; Massy ZA; Kamel S; Chillon JM; Choukroun G; Liabeuf S
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33530404
[TBL] [Abstract][Full Text] [Related]
34. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
Briskey D; Tucker P; Johnson DW; Coombes JS
Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
[TBL] [Abstract][Full Text] [Related]
35. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
Yamada S; Giachelli CM
Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
[TBL] [Abstract][Full Text] [Related]
36. Understanding and Therapeutic Strategies of Chinese Medicine on Gut-Derived Uremic Toxins in Chronic Kidney Disease.
Guo C; Rao XR
Chin J Integr Med; 2018 Jun; 24(6):403-405. PubMed ID: 29752692
[TBL] [Abstract][Full Text] [Related]
37. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
38. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
Glorieux G; Gryp T; Perna A
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future therapy.
Pongsuwan K; Kusirisin P; Narongkiattikhun P; Chattipakorn SC; Chattipakorn N
J Cell Physiol; 2022 Dec; 237(12):4369-4396. PubMed ID: 36183389
[TBL] [Abstract][Full Text] [Related]
40. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.
Addi T; Dou L; Burtey S
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
